Troponin Assay Adds Prognostic Ability to Cardiac CareÂ
A new high-sensitivity troponin test from Siemens can diagnose heart attacks but also predicts a patient’s risk of future cardiac events.
Category: Cardiovascular
Cardiovascular
Latest
Cardiovascular
Latest
Rapid Blood Test Can Diagnose Heart Attacks in Minutes
A new blood test can diagnose heart attacks in just 5-7 minutes, with potential applications for both clinical settings and at-home use.
Cardiovascular
Latest
ApoB Test May More Accurately Measure Heart Disease Risk
A study reveals that lipid panels may not fully capture the risk of cholesterol-related heart disease, highlighting a need for apoB testing.
FDA Clears Cardiac Troponin I Test for Myocardial Infarction Diagnosis
The new high-sensitivity troponin assay is designed for use on the the PATHFAST Biomarker Analyzer from Polymedco.
Read More
Heart Failure Monitoring Tech Doubles Sensitivity for Predicting Events Versus Standard of Care
Bodyport says its biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events.
Read More
Blood Biomarkers Help Predict Cardiovascular Disease Risk in Rheumatoid Arthritis Patients
The measurement of six blood biomarkers improved the ability of researchers to predict a future increase in arterial inflammation.Â
Read More
How a Standard Blood Test Helps Predict Heart Attacks
Combining the results of a standard blood test and an online tool can help identify those who are at risk of having a heart attack.
Read More
Biomarkers to Predict Cardiovascular Risks in Type 2 Diabetes Patients Identified
Researchers extracted data on 321 biomarkers and found 13 were significantly associated with cardiovascular risk in type 2 diabetes patients.
Read More
Two Common Biomarkers Predict Heart Risk in Asymptomatic Childhood Cancer Survivors
The biomarkers may help more quickly predict cardiomyopathy in high-risk, asymptomatic childhood cancer survivors.Â
Read More
Two-Step Screening Strategy Could Reduce Diabetic Heart Failure
A two-step screening protocol can effectively identify which patients with Type 2 diabetes need medication to prevent heart failure.
Read More
New Test Aids Emergency Diagnosis of Heart Conditions
Patients with a heart muscle injury caused by other heart conditions benefitted the most from the new troponin measurement method.
Read More
Bio-Rad Expands Instrument Compatibility for Cardiac Advance Control
Bio-Rad Laboratories expanded the compatibility of its newest cardiac control, Cardiac Advance, to now include Beckman-Coulter instruments. Â
Read More
Earlier Detection of Pediatric Cardiometabolic Risk Factors through Next-Gen Biomarkers
Next-gen cardiometabolic biomarkers will aid earlier detection of risk factors for obesity, diabetes, and heart disease in children.
Read More
Mindray Expands Cardiac Biomarker Portfolio with New Assays
Mindray introduced new cardiac biomarkers aimed at diversifying its portfolio for cardiovascular disease diagnosis and management.
Read More
New Blood Test Measures Levels of Critical Omega-3 Fatty Acids
Researchers discovered a way to track levels of omega-3 fatty acids in the bloodstream to gain information critical to cardiovascular health.
Read More
American College of Cardiology to Increase Cholesterol Screenings Through New Program
The national program will reach about 30,000 primary care providers and cardiologists, and will assess the state of LDL screenings.
Read More
Cardio Diagnostics Holdings Collaborates on Cardiovascular Health Initiative for Truckers
Cardio Diagnostics is collaborating with Truckers Health Network, an organization providing health and wellness options to truckers.
Read More
How Routine Genetic Testing Could Benefit Patients with an Advanced Heart Disease
A new study demonstrated the benefits of routine genetic testing for patients with advanced disease from dilated cardiomyopathy (DCM).
Read More